AVP and heart failure: Tolvaptan has been used in Europe and America since the late 2000s in patients with syndrome of inappropriate secretion of antidiuretic hormone, and several studies have reported its effectiveness in heart failure, and cirrhosis with hyponatremia [7, 8].